Company Valuation: AstraZeneca PLC

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 182,034 209,442 209,268 203,171 287,813 282,970 - -
Change - 15.06% -0.08% -2.91% 41.66% -1.68% - -
Enterprise Value (EV) 1 206,417 232,365 231,778 227,741 311,187 303,802 296,618 287,608
Change - 12.57% -0.25% -1.74% 36.64% -2.37% -2.36% -3.04%
P/E 1,469x 64.1x 35.4x 29.1x 28.4x 23.9x 20.6x 18.2x
PBR 4.24x 5.65x 5.39x 5.02x 5.96x 5.26x 4.56x 3.92x
PEG - 0x 0.4x 1.6x 0.6x 1.4x 1.3x 1.4x
Capitalization / Revenue 4.87x 4.72x 4.57x 3.76x 4.9x 4.46x 4.2x 3.96x
EV / Revenue 5.52x 5.24x 5.06x 4.21x 5.3x 4.79x 4.4x 4.02x
EV / EBITDA 27.2x 25.2x 17.1x 13.6x 16x 13.5x 12.1x 10.6x
EV / EBIT 20.8x 17.4x 15.9x 13.5x 16.8x 14.3x 12.7x 11.3x
EV / FCF 42.4x 26.7x 25.8x 22.9x 26.5x 33.3x 23.6x 19.6x
FCF Yield 2.36% 3.75% 3.88% 4.36% 3.78% 3.01% 4.24% 5.09%
Dividend per Share 2 2.87 2.9 2.9 3.1 3.2 3.331 3.543 3.656
Rate of return 2.44% 2.15% 2.15% 2.37% 1.72% 1.83% 1.94% 2%
EPS 2 0.08 2.11 3.81 4.5 6.54 7.625 8.854 10.01
Distribution rate 3,588% 137% 76.1% 68.9% 48.9% 43.7% 40% 36.5%
Net sales 1 37,417 44,351 45,811 54,073 58,739 63,376 67,393 71,464
EBITDA 1 7,586 9,237 13,580 16,691 19,476 22,571 24,455 27,029
EBIT 1 9,928 13,350 14,534 16,928 18,478 21,287 23,272 25,551
Net income 1 112 3,288 5,961 7,035 10,225 11,692 13,578 15,280
Net Debt 1 24,383 22,923 22,510 24,570 23,374 20,832 13,648 4,638
Reference price 2 117.51 135.16 135.02 131.05 185.60 182.44 182.44 182.44
Nbr of stocks (in thousands) 1,549,159 1,549,528 1,549,926 1,550,317 1,550,726 1,551,043 - -
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/10/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
41.9x14.18x30.07x0.48% 1,261B
41.35x6.94x19.51x1.89% 671B
37.55x8.61x17.78x2.34% 518B
22x5.33x13.34x2.45% 387B
102.54x5.86x24.97x2.35% 353B
24.41x5.87x14.28x2.7% 300B
24.28x4.86x13.64x1.8% 283B
23.87x7.33x13.47x2.18% 248B
-39.41x7.29x45.94x1.97% 211B
Average 30.94x 7.36x 21.45x 2.02% 470B
Weighted average by Cap. 37.00x 8.89x 22.54x 1.69%

Y-o-Y evolution of P/E

Valuation ratios - P/E - AstraZeneca PLC

Historical PBR trend

Valuation ratios - PBR - AstraZeneca PLC

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - AstraZeneca PLC

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - AstraZeneca PLC


Year-on-year evolution of the Yield

Valuation ratios - Yield - AstraZeneca PLC